CardioDx, Inc. to Present at the 11th Annual Needham Healthcare Conference
4/2/2012 10:44:05 AM
PALO ALTO, Calif.--(BUSINESS WIRE)--CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced that Chief Medical Officer Mark Monane, M.D., will present an overview of the company and of Corus®CAD, the first and only clinically validated gene expression test for obstructive coronary artery disease, at the 11th Annual Needham Healthcare Conference on Tuesday, April 3 at 10:40 a.m. ET at the New York Palace Hotel.
comments powered by